Oligonucleotide modulation of protein kinase c

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C12N 9/12 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2132094

2132094 9319203 PCTABS00025 Compositions and methods are provided for the treatment and diagnosis of diseases associated with protein kinase C. Oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding PKC. Oligonucleotides specifically hybridizable with a translation initiation site, 5'-untranslated region or 3'- untranslated region are provided. Oligonucleotides specifically hybridizable with a particular PKC isozyme or set of isozymes are also provided. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating protein kinase C expression with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to PKC are disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotide modulation of protein kinase c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotide modulation of protein kinase c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide modulation of protein kinase c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857199

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.